FacultyFaculty/Author Profile

Martin L. Perschetz

Schulte Roth & Zabel LLP

New York, NY, USA


Martin L. Perschetz is a partner in the New York office of Schulte Roth & Zabel, co-chair of the Litigation Group and a member of the firm's Executive Committee. He concentrates his practice in the areas of white-collar criminal defense, SEC enforcement, securities litigation and accountant's liability. With the firm for almost 25 years, Marty was previously an assistant U.S. attorney for the Southern District of New York, where he was chief of the Major Crimes Unit and led a team of prosecutors in the investigation and prosecution of federal criminal cases involving a wide variety of complex business and tax frauds. Immediately before coming to SRZ, he served as chief counsel to the Mayor of New York City's Special Commission to Investigate City Contracts and as deputy commissioner of the New York City Department of Investigation. Drawing on more than three decades of broad and deep prosecutorial, investigative, defense and trial experience, Marty has represented a wide array of clients in significant matters involving federal and state prosecutors, the SEC, the NYSE and FINRA, as well as in large and complex private civil litigation and in corporate internal investigations. His clients in recent securities and financial statement matters have included PricewaterhouseCoopers LLP and Big Four accounting firm auditors; investment funds Millennium Partners and The Clinton Group, and former senior officials at Merck, Vivendi Universal, Kmart Corp. and other large companies.

Most recently, in the Vivendi Universal matter, following a four-month trial in the Southern District of New York, the jury returned a verdict in favor of Marty's client, Vivendi's former Chief Financial Officer, on all claims against him. Believed to be the largest federal securities class action ever to proceed to a jury verdict, the case involved numerous complex issues under the antifraud provisions of the federal securities laws, and under U.S. and French Generally Accepted Accounting Principles. The American Lawyer named Marty a Litigator of the Week for his successful work on the Vivendi trial. In two ongoing federal securities class actions, Marty is representing a public company in the Central District of California, and, in the Merck securities litigation arising from the company's development and marketing of the pain reliever Vioxx, the former President of Merck Research Laboratories.

Martin L. Perschetz is associated with the following items:
Answer Book Chapters  Answer Book Chapters Scienter and Trading “on the Basis of” - Insider Trading Law and Compliance Answer Book (2018 Edition), Friday, November 03, 2017
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.